Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001396814-25-000087
Filing Date
2025-06-13
Accepted
2025-06-13 16:18:36
Documents
1
Period of Report
2025-06-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1749845910.html 4  
1 FORM 4 wk-form4_1749845910.xml 4 5652
  Complete submission text file 0001396814-25-000087.txt   7442
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 900 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 900 BRISBANE CA 94005 650-242-8052
Pacira BioSciences, Inc. (Issuer) CIK: 0001396814 (see all company filings)

EIN.: 510619477 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O PACIRA BIOSCIENCES, INC. 5401 WEST KENNEDY BOULEVARD, SUITE 890 TAMPA FL 33609
Business Address
Kronenfeld Mark A. (Reporting) CIK: 0001578074 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35060 | Film No.: 251046847